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Abstract
Chytridiomycosis, caused by the fungus Batrachochytrium dendrobatidis (Bd), is a widespread disease of amphibians
responsible for population declines and extinctions. Some bacteria from amphibians’ skins produce antimicrobial
substances active against Bd. Supplementing populations of these cutaneous antifungal bacteria might help manage
chytridiomycosis in wild amphibians. However, the activity of protective bacteria may depend upon environmental
conditions. Biocontrol of Bd in nature thus requires knowledge of how environmental conditions affect their anti-Bd activity.
For example, Bd-driven amphibian declines have often occurred at temperatures below Bd’s optimum range. It is possible
these declines occurred due to reduced anti-Bd activity of bacterial symbionts at cool temperatures. Better understanding of
the effects of temperature on chytridiomycosis development could also improve risk evaluation for amphibian populations
yet to encounter Bd. We characterized, at a range of temperatures approximating natural seasonal variation, the anti-Bd
activity of bacterial symbionts from the skins of three species of rainforest tree frogs (Litoria nannotis, Litoria rheocola, and
Litoria serrata). All three species declined during chytridiomycosis outbreaks in the late 1980s and early 1990s and have
subsequently recovered to differing extents. We collected anti-Bd bacterial symbionts from frogs and cultured the bacteria
at constant temperatures from 8uC to 33uC. Using a spectrophotometric assay, we monitored Bd growth in cell-free
supernatants (CFSs) from each temperature treatment. CFSs from 11 of 24 bacteria showed reduced anti-Bd activity in vitro
when they were produced at cool temperatures similar to those encountered by the host species during population
declines. Reduced anti-Bd activity of metabolites produced at low temperatures may, therefore, partially explain the
association between Bd-driven declines and cool temperatures. We show that to avoid inconsistent antifungal activity,
bacteria evaluated for use in chytridiomycosis biocontrol should be tested over a range of environmental temperatures
spanning those likely to be encountered in the field.
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Introduction
Emerging wildlife diseases can cause species declines and
extinction [1], and disease emergence and pathogenicity may
depend on environmental context [2]. Therefore, patterns of
decline and disease management strategies may be understood by
examining the effects of environmental context on disease
emergence. One way environmental context might affect disease
dynamics is by altering species interactions in the complex
assemblage of microbiota inhabiting wildlife [3]. Chytridiomyco-
sis, a disease caused by the fungal pathogen Batrachochytrium
dendrobatidis (Bd) and responsible for rapid and extensive population
declines in over 200 amphibian species since the late 1970s [4,5],
serves as a model system for understanding other wildlife diseases
[6]. Twenty years of research on Bd and its interaction with
amphibians and their environment can provide insight for anyone
interested in the effects of diseases on the conservation of wildlife
[5,7].
Currently, no effective treatments or preventative actions are
available to manage chytridiomycosis in wild populations of
threatened amphibians [8]. However, bioaugmentation, by
supplementing populations of anti-Bd bacteria, has proved
effective in laboratory trials and may be a viable option for
disease management if it also provides increased protection in
nature [9–11]. Previous experimental work on anti-Bd bacteria
was conducted under constant laboratory conditions [11,12].
However, naturally-occurring symbiotic bacteria, including anti-
biotic producers, vary in abundance and physiological activity with
environmental context [13–15]. This variation can affect the
success of biocontrol programs [16–18], and can have strong
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evolutionary and ecological impacts [3]. Bacteria chosen for
probiotic use based on high levels of anti-Bd activity under
constant conditions in the laboratory could have lower levels of
anti-Bd activity in the more variable conditions occurring in
nature. If this occurs, then choosing bacteria for use in the
management of chytridiomycosis, will require knowledge of how
candidate bacteria are affected by a range of environmental
conditions [9].
Environmentally induced variation in the protection afforded to
amphibian hosts by bacterial symbionts might also partially
explain patterns of past chytridiomycosis-driven declines. In the
tropics, where the impacts of chytridiomycosis have been most
severe, higher elevations and cooler seasons have been associated
with higher prevalences of infection, more intense infections, and
more frequent declines [19–24]. Bd’s relatively cool thermal
optimum (17–25uC) [25] may partially explain this pattern [21],
but many declines have occurred at temperatures well below this
window, where one might expect chytridiomycosis to be less severe
[26].
There are a number of reasons why declines might occur at very
low temperatures. In natural environments, Bd may respond to
low temperatures by increasing fecundity [27], and amphibian
hosts’ immune defenses may be weaker [28]. Another possible
contributor to the high incidence of Bd-driven declines at
temperatures below Bd’s in vitro thermal optimum is that symbiotic
cutaneous bacteria, which would otherwise reduce the severity of
chytridiomycosis, may have reduced activity or population density
at cooler temperatures. At present, there is no published
information on how the composition or antifungal activity of
assemblages of anti-Bd bacteria responds to changes in environ-
mental context.
To examine the effect of temperature on the production of anti-
Bd metabolites by bacteria, we sampled bacterial symbionts from
the Australian hylid frogs Litoria serrata and Litoria nannotis in 2010.
We also examined bacteria isolated by Bell [29] and Bell et al. [30]
from Litoria rheocola, L. serrata, and L. nannotis in 2009. All three
species experienced population declines following chytridiomycosis
outbreaks, although some populations have since recovered or
recolonized [23,31]. We identified the bacteria and characterized
their antifungal activity across a range of the temperatures
experienced by their amphibian hosts.
Materials and Methods
Ethics Statement
All procedures involving animals received clearance from the
James Cook University Animal Ethics Review Committee
(approval number A1316) and all field sampling was permitted
by the Queensland Department of Environment and Resource
Management (permit WITK05922209).
Collection and Isolation of Bacteria
To screen for anti-Bd activity, we collected bacteria from twelve
frogs (six L. serrata, six L. nannotis) caught at Windin Creek in
Wooroonooran National Park, Queensland, Australia (,750 m
a.s.l., S 17u219570 E 145u429540) in February 2010. We rinsed
each frog with a stream of sterile distilled water to remove non-
resident bacteria [32,33], then swabbed its dorsal and ventral
surfaces and legs twice, using a sterile rayon swab (MW112,
MWandE, Bath UK). We streaked each frog’s swab onto a low
nutrient agar plate (R2A, Becton, Dickinson and Company, New
Jersey, US). We used new gloves and plastic bags to catch, handle,
and hold each animal to prevent disease transmission or
contamination of samples. We released frogs at their point of
capture immediately after swabbing. After returning our samples
to the laboratory, we isolated each morphologically-distinct
bacterium into axenic (pure) culture using standard microbiolog-
ical techniques, and checked Gram stains of each isolate using light
microscopy to ensure purity [34]. Axenic isolates were stored on
ceramic Microbank microbeads (Microbank, Pro-Lab Diagnostics
U.K.). The beads are stored dry at 280uC. When a live culture is
required, a bead can be dropped into liquid media or streaked
across solid agar.
Identification of Anti-Bd Bacteria
To determine whether bacterial isolates inhibited growth of
Bd in vitro, we performed challenge assays using a method
developed by Bell et al. [30] with slight modifications described
here. We inoculated bacteria from Microbank microbeads into
one mL TGhL broth (eight g tryptone, one g gelatine, two g
lactose per liter of water) in 24-well plates (Costar 3524, Corning,
New York, US) and incubated them for 48-hours at 23uC. We
then centrifuged each liquid culture for five minutes at 75006g,
and filtered the supernatant through a 0.22 mm syringe filter
(Millex GV, Millipore, Massachusetts, US). This left a cell-free
supernatant (CFS) containing bacterial metabolites.
In 96-well assay plates (Costar 3595, Corning, New York, US),
we inoculated 1.06105 live Bd zoospores (isolate Gibbo River, L.
Les, 06-LB-1 isolated by L. Berger in 2006 from a Litoria lesueri and
passaged weekly) suspended in 50 mL of fresh TGhL into each of
five replicates containing 50 mL of each CFS. We included
replicates of positive and negative controls consisting of 1.06105
live and heat-killed Bd zoospores, respectively, suspended in
100 mL TGhL. We incubated the plates at 23uC and monitored
progress of Bd growth in each well with daily spectrophotometric
readings at 492 nm [35]. We continued monitoring until
maximum growth was observed in the positive control and in
the majority of wells containing CFS (four days). This is the most
conservative point in the assay at which to determine anti-Bd
activity; i.e., this is the point at which the ratio of Bd growth in
CFSs to Bd growth in the positive control is maximized. We
examined 96-well plates using light microscopy and excluded from
our analyses any replicates that had become contaminated.
We transformed mean optical densities at 492 nm (OD492) for
each isolate-temperature combination on each day, to correct for
initial coloration of CFSs (by subtracting the mean initial OD492)
and background absorbance of inoculated zoospores on that day
(by subtracting the mean negative control OD492) [30]. Using the
corrected value on the maximum growth day for both the positive
control and for each CFS by temperature combination, we
standardized isolate-specific values against the similarly corrected
value for the positive control. This produced a measure of Bd
growth in each CFS by temperature combination as a proportion
of that in the positive control. Finally, we multiplied the corrected
and standardized values by 100 percent. This returned the
following values: 100% for the positive control; 0 for total
inhibition of Bd growth; .0 but ,100% for partial inhibition, and
.100% for CFSs in which Bd grew better than in the positive
control. Thus, the values are the percent Bd growth relative to that
in the positive control. Following Bell et al. [30] we considered
CFSs in which Bd growth was reduced on average at least 63.5%
below that in the positive control to be strongly inhibitory. This
value is a conservative correction for the maximum observed
effects of nutrient depletion in the media carried into challenge
assay wells along with inoculated CFSs. When Bd is inhibited more
than 63.5%, it is assumed to be true CFS-driven inhibition, and
not due to nutrient depletion [30].
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We extracted DNA from each isolate that strongly inhibited Bd,
first by three freeze-thaw cycles of 10 minutes each at 280uC and
70uC, and then, if freeze-thaw cycles alone did not yield sufficient
DNA for successful PCR, using a Qiagen (Hilden, Germany)
DNeasy blood and tissue kit with pretreatment for Gram-negative
bacteria, as per the manufacturer’s protocol. DNA was amplified
using universal bacterial 8F and 1492R primers [36], and
sequenced by Macrogen, Inc. (Seoul, South Korea). We aligned
forward and reverse sequences in Geneious [37] and matched to
sequences in the NCBI GenBank database (http://ncbi.nlm.nih.
gov) to identify bacteria. We have submitted genetic sequence data
to GenBank.
Experimental Challenge Assays
To test for temperature-induced changes in bacterial anti-Bd
activity we performed additional challenge assays and quantitative
analysis using bacteria identified in the initial screening assay as
strongly inhibitory. In addition to the bacteria isolated from frogs
sampled in February 2010, we included strongly inhibitory
bacteria isolated from Litoria nannotis, L. serrata, and L. rheocola at
Windin Creek in the Austral winter of 2009 and tested using the
methods described above [29]. In total, we tested 24 isolates in the
experimental challenge assays, all of which inhibited Bd growth by
more than the 63.5% threshold in initial challenge assays (Table 1).
We inoculated each bacterium from a Microbank microbead
into a 25 cm2 flask (TPP, Trasadingen, Switzerland) containing
10 mL TGhL broth and incubated it at 23uC for at least 48 hours
until growth was observed. We then added 500 mL of each
bacterial inoculum to one mL TGhL in each of six, 24-well plates.
One plate was placed in each of six incubators set at 8, 13, 18, 23,
28, and 33uC, respectively. We chose temperatures to approxi-
mate the range of conditions experienced by Litoria spp. in the
Australian Wet Tropics [38].
We grew bacterial cultures for two to five days, based on the
time to maximal absorbance at 492 nm (a surrogate for maximal
bacterial concentration) and used these cultures to produce the
CFSs included in the next round of challenge assays. Growing
cultures to maximum absorbance minimized any differences
among treatments that might have arisen if metabolite production
was triggered by quorum sensing, a mechanism of detection and
response in bacterial colonies based on population density [39].
When OD492 stopped increasing (qualitatively determined from
the plateauing of absorbance values) we produced bacterial CFSs
as described for the initial screening assay. We harvested each
individual bacterium as it reached maximum growth; i.e, we did
not wait for absorbance of all bacteria in a plate to plateau before
harvesting. This method does not account for possible differences
in the maximum achievable concentration of any given bacterium
at different temperatures. CFSs were held at 220uC until use in
the challenge assays. We completed challenge assays at 23uC with
five replicates inoculated from each growth treatment temperature
for each bacterium’s CFS, and with 2.96104 zoospores initially
inoculated in each 100 mL assay well. Bd was therefore not
cultured at a range of temperatures; only the bacteria used to
produce CFSs were. This allowed us to evaluate the effects of
temperature on the bacteria independent of the well-known effects
of temperature on the growth of Bd [25]. We removed from the
analysis any replicates that appeared to be contaminated when
observed by light microscopy. As in the initial assays, the challenge
assays continued until maximum growth was achieved in the
positive controls (here six days).
Statistical Analysis
Corrected and standardized absorbance data were averaged
across replicates of each CFS-temperature combination. The
resulting averages were not normally distributed and could not be
normalized by standard transformations. Therefore, we used a
Kruskal-Wallis test to examine the effects of temperature on the
anti-Bd activity of CFSs from tested bacteria. We performed
analyses in S-PLUS (version 8.0, Insightful Corporation, Seattle)
and R 3.0 (R core team, 2013).
Results
Identification of Anti-Bd Bacteria
Four of 720 replicates (0.6%) were removed from the initial
challenge assay due to contamination. Bd growth expressed
relative to the positive control was not normally distributed
among CFSs in the initial screening assay (Figure 1). Thirty-seven
percent of CFSs tested at this stage inhibited Bd growth strongly.
Bd grew poorly or not at all when exposed to these CFSs (Figure 2).
We also observed a small number of CFSs (e.g., Pseudomonas sp.
SBR3-slima, Figure 3) that apparently enhanced Bd growth, a
phenomenon also reported by Bell et al. [30].
After removing duplicate isolates that came from the same
individual frog and matched identical GenBank entries, 16
distinct, strongly inhibitory bacterial isolates remained from
samples collected in 2010. These 16 matched the 13 operational
taxonomic units (OTUs) listed for 2010 in Table 1; one OTU was
found on two frogs, and one was found on three. Pseudomonads
constituted six of the 13 OTUs, making them the most common
group among inhibitory bacteria. The strongly inhibitory isolates
collected in 2009 and included in experimental assays are also
listed in Table 1.
Experimental Challenge Assay
The experimental challenge assay continued for six days, at
which point Bd in the positive control and in 136 of 157 CFSs had
reached its maximum growth. All the 21 remaining CFSs had Bd
growth and absorbances already well above the point at which
they would have been considered inhibitory. Forty-one of 785
replicates (5.2%) became contaminated and were subsequently
removed from analysis of the initial challenge assay. Bacterial
responses to temperature included all of increased, decreased, and
non-directional changes to CFS anti-Bd activity (Figure 3).
The temperature at which bacteria were cultured significantly
affected the antifungal activity of their CFSs (Kruskal-Wallis test,
x2 = 15.35, df = 5, p,0.01). Antifungal activity tended to be lowest
in CFSs produced at 8uC (Figure 4). Using the cutoff from the
initial screening assay of 63.5% or greater inhibition of Bd growth
relative to the positive control, 46% of tested CFSs had no strong
antifungal activity when produced at 8uC, whereas no more than
28% produced at any of the warmer temperatures lost strong
antifungal activity.
Bell et al. [30] observed various fungicidal (leading to the
breakdown of Bd cells) and fungistatic (arresting Bd’s life cycle)
effects of CFSs on Bd. We observed similar effects in the cultures
we monitored visually by light microscopy. For example, in the
CFSs of Pseudomonas fluorescens strain 1408 grown at 8uC, the
zoospores of Bd appeared dead and deformed, whereas in the
CFSs of Chryseobacterium sp. CH33 grown at 8uC, zoospores
developed into sporangia without producing viable zoospores.
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Discussion
Variation in Antifungal Activity
The metabolites of many of the defensive bacterial symbionts of
amphibians we tested had reduced antifungal activity when
produced at 8uC. Such reductions in anti-Bd activity were likely
caused by changes in the quantity, identity, or both of bacterially-
produced substances, and could have contributed to chytridiomy-
cosis-driven declines that occurred in high elevation populations of
the three Litoria species sampled here [23,31,40]. Winter air
temperatures in the high elevation habitats of these species can
often be lower than 8uC [26,41]. Therefore, frogs may experience
decreased bacterial protection from Bd in winter, which in
Australia and elsewhere is when chytridiomycosis causes greater
morbidity and mortality [19,23,42]. While Bd physiology may also
be altered under variable temperature regimes and it will be
important to test bacteria and Bd exposed together to a range of
temperatures, our design and the in vitro assay we used did not
allow for testing such effects. Nonetheless, our experiment is an
incremental step towards understanding context-dependency in
amphibian-Bd-bacteria interactions.
Anti-Bd bacteria occur on a wide geographic and phylogenetic
range of amphibians [12,43,44], and the pattern that chytridio-
mycosis is more virulent at cool temperatures is also widespread
[19–21,23]. Many bacteria can alter their rates of antibiotic
production in response to environmental temperatures [17,45,46].
Table 1. Bacteria identified as strongly inhibitory of Batrachochytrium dendrobatidis and used in the experimental challenge assay.
Taxonomic name Frog species`, Year GenBank Accession ID, % Matching* GenBank Accession Number
Actinobacteria
Microbacterium sp. HY14(2010) LN, 2010 HM579805, 99.5 KJ191412
Bacilli
Bacillus thuringiensis isolate CCM15B LN, 2010 FN433029, 99.8 KJ191418
b-Proteobacteria
Uncultured Silvomonas sp. clone ntu63 LS, 2010 EU159476, 98.5 KJ191396
Bacterium H2 LR, 2009 AY345552, 99.1 KJ191380
Iodobacter sp. CdM7 FJ872386, 98.8
Flavobacteria
Chryseobacterium sp. CH33 LN, 2009 GU353129, 99.1 KJ191375
Uncultured bacterium clone nbw1150f04c1 LS, 2010 GQ082309, 99.1 KJ191421
Chryseobacterium hispanicum type strain VP48 AM159183, 98.7
c-Proteobacteria
Hafnia alvei LN, 2009 AB519795, 99.9 KJ191378
Pseudomonas fluorescens strain 1408 LS, 2009 GU726880, 99.9 KJ191384
Pseudomonas fluorescens strain d3_16s LS, 2010 HQ166099, 99.7 KJ191426
Pseudomonas fluorescens strain KU-7 LR, 2009 AB266613, 98.9 KJ191386
Pseudomonas koreensis strain Ps 9–14 LR, 2009 NR025228, 99.9 KJ191376
Pseudomonas koreensis strain SSG10 LN(3), 2010 HM367598, 99.8; 99.8; 99.7 KJ191409
Pseudomonas koreensis strain SSG5 LN, 2010 HM367599, 99.9 KJ191405
Pseudomonas mosselii strain WAB1873 LN, 2010 AM184215, 99.7 KJ191414
Pseudomonas mosselii strain R10 LN, 2010 DQ073452, 99.6 KJ191411
Pseudomonas putida strain PASS3-tpnb LR, 2009 EU043325, 99.7
Pseudomonas sp. SBR3-slima LN, 2010 EU043328, 99.3 KJ191420
Pseumonas tolaasii strain NCPPB 2325 LR, 2009 AF320990, 100
Serratia marcescens strain C1 LS(2), 2010 GU220796, 99.9; 99.7 KJ191397
Stenotrophomonas maltophilia strain 6B2-1 LR, 2009 AB306288, 99.9 KJ191382
Stenotrophomonas maltophilia strain YLZZ-2 LS, 2009 EU022689, 99.6 KJ191387
Stenotrophomonas sp. 7-3 LR, 2009 EU054384, 99.6 KJ191381
Uncultured bacterium clone nbw969a06c1 LN, 2010 GQ043359, 98.4 KJ191393
Xanthomonas sp. CC-AFH5 DQ490979, 98.1%
Uncultured bacterium clone P7D82-747 LN, 2010 EF509545, 99.6 KJ191417
Stenotrophomonas sp. TSG4 HM135101, 99.6%
Where the closest GenBank match was an unnamed bacterium, the closest named match is included immediately below (smaller, bold text) to give the best possible
sense of phylogeny.
*Where more than one inhibitory isolate most closely matched the same OTU, the percent matching is listed for both. We used the isolate with the first listed percent
matching for the experimental challenge assay.
`LN = Litoria nannotis, LR = Litoria rheocola, LS = Litoria serrata; (number of individuals from which the bacteria was isolated, if .1).
doi:10.1371/journal.pone.0100378.t001
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Like the Litoria spp. we sampled, other amphibians may be more
vulnerable to chytridiomycosis at cool temperatures if their
bacterial protection from Bd is reduced. Larger scale, longitudinal
studies characterizing the diversity and abundance of amphibian
bacterial symbionts and their metabolites, Bd infection loads, and
chytridiomycosis severity across environmental gradients and
among seasons, are required to test this hypothesis.
Although the general trend was towards decreased anti-Bd
activity when CFSs were produced at cooler temperatures, some
bacteria did not show unidirectional responses to temperature
(e.g., Pseudomonas sp. SBR3-slima, Figure 3); they produced
metabolites without anti-Bd activity at the lowest temperature
and at moderate temperatures. These complex temperature
responses may have been caused by production of different
antibiotics at different temperatures. Many bacteria produce more
Figure 1. Frequency (%) of the bacterial isolates which produced cell-free supernatants (CFS) showing a change in Bd growth
relative to the positive control (Bd alone; 100%) for 110 isolates screened in the initial challenge assay. A bimodal pattern of activity
was observed. The arrow indicates the cutoff for considering a CFS strongly inhibitory ($63.5% inhibition relative to the positive control, i.e., #36.5%
the growth of the positive control). Thus, black bars represent strongly inhibitory CFSs and the highest bar at the far left represents those isolates
producing cell-free supernatants showing 100% inhibition.
doi:10.1371/journal.pone.0100378.g001
Figure 2. Example growth curves ±SD of the positive control, the negative control, two inactive, and two strongly inhibitory cell-
free supernatants from an initial screening assay. Higher optical density at 492 nm (y-axis, OD492) indicates greater Bd growth. Day 0 OD492
varies with original cell-free supernatant color, which is corrected for in calculations (see Methods).
doi:10.1371/journal.pone.0100378.g002
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than one antibiotic [45], and some regulate their production
through multiple genes [47] that could possess different temper-
ature thresholds.
We selected the bacteria we tested in the experimental challenge
assay because their supernatants were inhibitory when produced at
23uC in the initial screening assay. It is possible that a different
subset of the entire sampled bacterial community could have been
classed as inhibitory if the CFSs for the initial screening assay had
been produced at different temperatures. One of our aims,
however, was to document context-dependency in bioaugmenta-
tion candidates identified as inhibitory in ‘standard’ challenge
assays conducted at 23uC [12,30]. Conducting this sort of
laboratory assay under ecologically-relevant conditions has been
identified as a necessary step towards selecting effective bioaug-
mentation strategies [9]. However, it is entirely possible that some
bacteria that live on the skin of the Litoria species we sampled are
effectively antifungal at low temperature and were not selected
because they are not inhibitory at 23uC. Equally, the possibility of
density-dependent responses of Bd to CFSs, if for example
zoospores can degrade some bacterial products in the CFSs,
means that had we conducted the initial challenge assay using
more or fewer zoospores, different bacteria may have been
identified as inhibitory and subsequently included in the exper-
imental challenge assay. We used slightly different concentrations
of Bd zoospores in the initial and experimental challenge assays
due to temporal variation in the productivity of laboratory Bd
cultures. However, all CFSs tested in the experimental challenge
assay were inoculated with the same concentration of Bd zoospores
and therefore any possible density-dependent responses of Bd to
CFSs could not have affected the temperature-driven effects on
CFS anti-Bd activity reported here.
To produce CFSs for the experimental challenge assay, we grew
bacterial cultures to maximum absorbance in each temperature
treatment. Because some bacteria may have been dying and their
cells breaking apart at this stage, it is possible that these by-
products, in addition to anti-fungal metabolites produced by live
bacteria, could be partially responsible for observed anti-Bd
activity. If bacteria died and broke apart to a greater extent in
the higher temperature treatments, it could explain some of the
reduced anti-Bd activity at 8uC. Further experiments employing
chemical methods will be needed to definitively identify and
evaluate the products responsible for differential anti-Bd activity of
CFSs.
Our present study is the latest to find a substantial number of
Pseudomonas species, a well-known group of antibiotic producers
[45,48], among the antifungal cutaneous microbiota of amphib-
ians [12,30,40,49]. Walke et al. [44] offered several ecological and
physiological reasons for the prevalence of Pseudomonads among
the defensive microbiota of amphibians. Our results show that the
anti-Bd activity of at least some Pseudomonads depends on
Figure 3. Growth curves (uncorrected optical density at 492 nm, OD 492 nm) vs. day of the experimental challenge assay for Bd
growth in cell-free supernatants from four bacteria chosen as examples to show the range of responses observed following the
temperature treatments applied during cell-free supernatant production. Values are means 6SD. Where not visible, SD bars are smaller
than the plotted symbols. All bacterium-temperature combinations have N= 5 replicates in the challenge assay, except P. fluorescens with N=4 at
23uC and 18uC, N = 3 at 33uC and no data at 13uC due to contamination. Cell-free supernatants were produced once at each temperature.
doi:10.1371/journal.pone.0100378.g003
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environmental context (e.g., Pseudomonas sp. SBR3-slima, Figure 3).
Only the most robustly antifungal isolates should be used in
bioaugmentation, regardless of how common they may be.
Management Implications and Future Research
Bacterial antifungal activity observed under a narrow spectrum
of laboratory conditions could be lost on exposure to variable field
environments. Using antifungal bacteria with inconsistent activity
in bioaugmentation efforts could cost managers time and
resources, and could create the illusion that bioaugmentation is
less effective than if more appropriate isolates were used. Even
closely related bacteria may respond differently to environmental
variations, as did the Pseudomonads in Figure 3. One produced
strongly antifungal metabolites across the entire 8–33uC range,
whereas at 8uC others produced metabolites with no antifungal
activity.
Only a few studies have characterized the metabolic products of
amphibian symbionts [50–52]. Based on our observations of
varied responses of Bd to CFSs from different bacteria, and the
phylogenetic range represented in addition to the many Pseudo-
monads found, it is likely that a variety of different antifungal
compounds were produced by the bacteria we tested. As
mentioned above, future workers should seek to identify these
compounds, so that it is possible to measure their concentrations
on amphibian skin.
Our study focused on environmental context-dependent
changes in the bacterial production of anti-Bd metabolites, but
not on possible context-dependent changes in the fungus itself, or
in the direct interaction between bacteria and Bd on the skins of
live frogs. This study constitutes a step towards understanding
environmentally induced variation in the amphibian-Bd-bacteria
symbiosis, but no study has yet simultaneously assessed the
responses of both Bd and bacteria to varying temperatures.
Additionally, no mesocosm or field study of bioaugmentation in a
natural environment has been published to date, and a host of
questions remain surrounding the best methods of application of
beneficial bacteria, non-target effects, and the term of protection
afforded. Carrying out Bd-bacteria research in vivo, and ultimately
in natural systems, will be necessary preliminary steps for
bioaugmentation application, even if interpretation of specific
experimental treatments is complicated. Given the opportunity to
apply bioaugmentation for restoration and protection of many
amphibian species globally, it is most important to develop
effective management protocols for use with robustly-antifungal
bacteria commonly found on target species’ skin.
Research on the drivers of other wildlife diseases should also
consider the possible effects of environmental context dependence.
Some coral disease is exacerbated by warmer environmental
temperatures [53]. White-nose syndrome in bats is driven by
changes in the temperature of bat hibernacula, which may allow
management by artificial temperature regulation in caves [54]. In
the case of chytridiomycosis, seasonal and local temperature
variation are important, both for their direct effects on the host-
pathogen relationship [3,55] and because they modify relation-
ships within the skin microbe assemblage as described here. The
effects of environmental context can thus occur through multiple
pathways and can determine the extent to which a disease
threatens biodiversity. A thorough understanding of environmen-
tal context dependence must therefore be a priority when
designing disease management strategies.
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